Loading…
AlgiSys BioSciences is scaling up a fermentation-based platform using non-GMO microalgae to produce EPA-rich ingredients for aquafeed, initially targeting Atlantic salmon. The company is planning feeding trials and prioritizing commercialization, aiming to address limited commercial-scale availability of EPA compared with DHA.
A scalable alternative EPA source could diversify aquafeed omega-3 supply and reduce reliance on existing marine or algal ingredients. Any impact on feed-ingredient prices remains prospective while the technology is being scaled and tested.
aquafeed.comAquafeed Media SLUNov 9, 2026Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
